ences and Nagoya City Sports and Rehabilitation Center. All patients provided written informed consent to participate in the study.
C-Palmitate PET
The PET study was performed using a whole body, multislice positron tomograph (PCT 3600W, Hitachi Medical Co, Tokyo, Japan). This camera has 8 rings that simultaneously provide 15 slices of the tomographic images at 7-mm intervals and an in-plane resolution of 10 mm as full width at half maximum. After obtaining a 20-min transmission scan to correct for attenuation, 370 MBq of 11 C-palmitate were administered intravenously for 2 min. A dynamic PET scan was begun 1 min after the start of administration, with acquisition of 20 image frames over 20 min. The images were reconstructed 60 s each. On each patient's midventricular transaxial image, 11 or 12 regions of interest (ROI) (10 mm in diameter) were equidistantly placed to cover the entire LV wall. Time -activity curves of 11 C-palmitate in these ROIs were generated from serial PET values after corrections for dead time and physical decay.
C-Acetate PET
Four hours after the 11 C-palmitate PET studies, 370 MBq of 11 C-acetate were again administered intravenously for 2 min and 1 min after the beginning of administration, dynamic PET scanning was started and 20 image frames were acquired over 23 min as reported previously. 5 The 11 Cacetate PET images were obtained as follows: each of the first 6 frames was acquired over a 30-s period during the first 3 min; each of the next 7 frames was acquired over a 60-s period (3-10 min); finally, each of the last 7 frames was acquired over a 120-s period (10-24 min). On each patient's midventricular transaxial image, ROIs that corresponded to those used in the 11 C-palmitate PET study were placed on the LV wall. Time -activity curves of 11 C-acetate were also obtained as before.
Biplane LVG
Biplane (30-degree right anterior oblique and 60-degree left anterior oblique) LVG was performed. Two experienced observers reviewed the wall motion observed in the regions corresponding to the ROIs of the PET studies. Wall motion was scored as follows: normal =3, hypokinesis =2, and akinesis =1.
Data Analysis
11 C-Palmitate PET Study We obtained 11 C-palmitate peak counts as an index of initial myocardial 11 C-palmitate uptake and calculated a percent clearance of 11 C-palmitate during the acquisition in each ROI with the following formula:
Percent clearance (%) = (peak counts -counts at the end of acquisition)/peak counts ×100
In addition, from the time -activity curve of 11 C-palmitate, a clearance rate constant (palmitate-Kmono) was calculated by fitting a monoexponential equation using the least squares method in each ROI and a coefficient of determination (R 2 ) was obtained. 1, [6] [7] [8] The monoexponential equation was applied to the 11 C-palmitate time -activity curve after it had reached its peak count. We found some regions where the time -activity curves were poorly fitted to a monoexponential curve. Thus, all ROIs were classified into 2 groups based on the R 2 values: the time -activity curve fitted well (R 2 ≥0.5) or poorly to a monoexponential curve (R 2 <0.5). In the univariate regression analysis, an R 2 value indicates a percentage that the variance of 1 parameter explained by the other. If the R 2 value is more than 0.5 in the relation between the 11 C-palmitate counts and the time in a ROI, this means that the variance of 11 C-palmitate counts during acquisition is explained by the time more than 50%, indicating 11 C-palmitate clearance strongly depends on the time course. In contrast, if the R 2 value is less than 0.5 in this relation, 11 C-palmitate clearance is explained less than 50% by the time, suggesting 11 C-palmitate clearance does not mainly depend on the time course.
It is known that if fatty acid -oxidation works well in the myocardium, 11 C-palmitate is rapidly metabolized by -oxidation and washed out from the myocardium as 11 CO2 after its injection, and thus prompt 11 C-palmitate clearance should be described by a monoexponential function during 20 min after injection. [6] [7] [8] In such regions, the R 2 values of the exponential relations are expected to be more than 0.5, because -oxidation produces a rapid decrease of 11 Cpalmitate counts in a strongly time dependent manner. In contrast, the finding that 11 C-palmitate clearance is poorly fitted to a monoexponential curve suggests that fatty acid -oxidation in the myocardium does not work well. In the regions with impaired fatty acid -oxidation, significant back diffusion of 11 C-palmitate from the myocardium to the capillaries and a metabolic shift of 11 C-palmitate from rapid oxidation to incorporation into triglycerides should exist. [9] [10] [11] The continuous back diffusion and extraction in the myocardium may produce scattered 11 C-palmitate activity against the time axis. The metabolic shift is most evidently observed more than 15 min after injection of 11 Cpalmitate, which is close to the end of acquisition in our protocol. 10, 11 These factors should slow the 11 C-palmitate clearance with dispersion of its activity from the expected monoexponential regression line by -oxidation and should reduce the R 2 value until it reaches <0.5. Accordingly, we hypothesized that in regions with an R 2 value ≥0.5, fatty acid -oxidation works well, whereas in those with an R 2 value <0.5, it does not.
11 C-Acetate PET Study Similar to the 11 C-palmitate study, a clearance rate constant for 11 C-acetate (acetateKmono) and a coefficient of determination were calculated from the time -activity curve for each ROI as an index of regional total myocardial oxidative metabolism. 3, 5, [12] [13] [14] [15] [16] [17] A monoexponential curve was also applied to the phase of decreasing 11 C-acetate activity after it had reached its peak count. In the 11 C-acetate PET study, a monoexponential curve fitted the time -activity curve well in all regions. From the counts of 11 C-acetate from 60 to 180 s after its injection, the sum of myocardial uptake of 11 C-acetate in this phase was calculated for each ROI. Then, profiles of percent uptake of 11 C-acetate in the LV walls were generated. We regarded the percent uptake of 11 C-acetate as an index of relative regional myocardial blood flow. 16, 18, 19 
Statistical Analysis
Data are expressed as mean ± standard deviation. Relationships between 2 parameters were evaluated using univariate linear regression analysis. Differences between 2 groups were assessed using unpaired Student's t-test. Differences among 3 groups were evaluated using using oneway ANOVA with a Bonferroni adjustment. Differences with p values less than 0.05 were considered significant.
Results
In all 155 regions, significant (p<0.001) differences were observed in acetate-Kmono values among the areas with normal LV wall motion (0.0694±0.0081 min -1 , n=71), the areas with hypokinesis (0.0544±0.0057 min -1 , n=63), and those with akinesis (0.0411±0.0091 min -1 , n=21) (Fig 1) . Relative myocardial blood flow correlated significantly with acetate-Kmono in all regions (r=0.54, p<0.001) (Fig 2) .
The heart rate -systolic blood pressure product did not differ between the palmitate and acetate PET studies (9,038±1,797 vs 8,869±2,005 mm Hg·min -1 , NS).
Representative 11 C-palmitate time -activity curves are shown in Fig 3. There were 2 types: 11 C-palmitate clearance from the myocardium that was well fitted to a monoexponential curve (Fig 3A) and poorly fitted (Fig 3B) . Peak 11 Cpalmitate uptake (14,434±3,052 vs 12,016±3,088 counts/s, p<0.001) and percent clearance during acquisition (38.2± 10.1 vs 23.6±11.4%, p<0.001) were significantly greater in the regions with well-fitted 11 C-palmitate time -activity curves (n=111) than in those with poorly fitted curves (n=44) (Fig 4) . Relative myocardial blood flow (86.0±9.2 vs 67.2±17.8%, p<0.001) and acetate-Kmono value (0.0641± 0.0099 vs 0.0476±0.0103 min -1 , p<0.001) were significantly higher in the former than in the latter. The LV wall motion score was also significantly higher in the former regions (2.64±0.48 vs 1.52±0.51, p<0.001) (Fig 5) .
In the 111 regions with well-fitted 11 C-palmitate timeactivity curves, 71 had normal LV wall motion and 40 had hypokinesis. No region showed akinesis. In contrast, in the 44 regions with poorly fitted 11 C-palmitate time -activity curves, 23 had hypokinesis and 21 had akinesis; none showed normal wall motion. In the regions with well-fitted 11 C-palmitate time -activity curves, the palmitate-Kmono value was significantly higher in the areas with normal wall motion than in those with hypokinesis (0.0363±0.0062 vs 0.0274±0.0057 min -1 , p<0.001) (Fig 6) . Acetate-Kmono was also significantly higher (0.0694±0.0081 vs 0.0548± 0.0047 min -1 , p<0.001) and myocardial blood flow was relatively greater in the former regions than in the latter (87.1±7.8 vs 83.9±11.1%, p=0.074). A significant positive correlation between palmitate-Kmono and acetate-Kmono was observed in the 111 regions (r=0.48, p<0.001). In the graph (Fig 7) , if attention is paid to the regions with palmitateKmono <0.035, one notices that the patients with normal wall motion had higher acetate-Kmono values than those with hypokinetic wall motion. Statistically, acetate-Kmono in the former was significantly higher than in the latter (0.0683±0.0050 vs 0.0548±0.0047 min -1 , p<0.001). The relation between the acetate-Kmono and LV wall motion in 44 regions with poorly fitted 11 C-palmitate clearance curves is superimposed to the left of the graph. In these regions, we did not calculate palmitate-Kmono values because the statistical meaning of palmitate-Kmono with the R 2 value of <0.5 was considered to be vague. Interestingly, some of these poorly fitted regions had relatively better acetate-Kmono; however, local LV wall motion in such regions was not normal but hypokinetic.
Significant differences were observed in the R 2 values of monoexponential fitting for 11 C-palmitate clearance among the regions with normal LV wall motion, those with hypokinesis, and those with akinesis (0.78±0.01 vs 0.57±0.22 vs 0.41±0.18, p<0.001). The lower 95% confidence interval (CI) of the mean R 2 value in the regions with hypokinetic LV wall motion was 0.51. On the other hand, the upper 95% CI of the mean R 2 value in the regions with akinesis was 0.49. A significant positive correlation was found between the R 2 values of monoexponential fitting for 11 Cpalmitate clearance and palmitate-Kmono values (Fig 8) .
Discussion
In patients with prior MI who undergo coronary reperfusion therapy, initial myocardial 11 C-palmitate uptake is high, with better 11 C-palmitate percent clearance in the regions having 11 C-palmitate clearance well fitted to a monoexponential curve. In these regions, myocardial blood flow, total myocardial oxidative metabolism, and LV wall motion are preserved. In contrast, these parameters are deteriorated in the regions having poorly fitted 11 C-palmitate clearance curves. We also demonstrate that the R 2 value of 0.5 is a clinically important index for distinguishing those regions with better 11 C-palmitate -oxidation.
Monoexponential Fitting in the Evaluation of Fatty Acid -Oxidation and Total Oxidative Metabolism
In the normal myocardium, -oxidation of long-chain fatty acids plays a major role in energy generation, whereas in ischemic or damaged myocardium, -oxidation of fatty acid metabolism is easily and greatly suppressed 1 and glucose metabolism becomes the major energy source. 2, 3 Thus, overall myocardial oxidative capacity cannot be assessed by analyzing the metabolism of any one substrate Relationship between palmitate-and acetate-Kmonos in the regions where 11 C-palmitate clearance was well-fitted to a monoexponential curve. A significant positive correlation was found. In the left part of the graph, the relation between acetate-Kmono and LV wall motion in regions where a monoexponential curve could not be fitted for 11 C-palmitate clearance is superimposed. Several regions belonging to this group had relatively better acetate-Kmono but it was less than 0.06 min -1 . alone. 12 It is known that acetate metabolism reflects the activity of the tricarboxylic acid cycle in the mitochondria. Thus, many investigators have reported that the clearance rates of 11 C-acetate evaluated by PET correlate closely with overall myocardial oxygen consumption in normal, ischemic, and infarcted myocardium. 5, [12] [13] [14] [15] [16] [17] [20] [21] [22] The clearance rate constant Kmono, calculated by applying a monoexponential equation to the clearance curve of 11 C-acetate, has been used as an index of regional myocardial oxidative capacity. 3, 5, [12] [13] [14] [15] [16] [17] On the other hand, fatty acid metabolism can be estimated noninvasively using 11 C-palmitate PET. Several investigators have reported that the clearance curve of 11 Cpalmitate is bi-exponential: the early rapid phase reflects -oxidation of fatty acid and the late slow phase represents turnover of the esterified lipid pool. [6] [7] [8] 10, [23] [24] [25] Schöhn et al reported that in canine hearts, the relative extent of the early rapid clearance of 11 C-palmitate to the total clearance and the half-time of the early rapid clearance curve correlate closely with regional myocardial oxygen consumption and also to the rate of 11 CO2 production in normal and ischemic myocardium. 23, 24 In human studies, because clearance of 11 C-palmitate is slower than in animal hearts, monoexponential curve fitting has often been used for quantitative assessment of the early rapid phase of 11 Cpalmitate clearance. 1,6-8 Thus, we used the Kmono of 11 Cpalmitate clearance as an index of fatty acid -oxidation. However, in contrast to 11 C-acetate clearance curve, there were some regions where 11 C-palmitate clearance could not be fitted to a monoexponential curve (R 2 <0.5). In such regions, we substituted peak 11 C-palmitate uptake and percent clearance of 11 C-palmitate for the Kmono as indices of palmitate metabolism. The myocardial regions having good fatty acid -oxidation should have a relatively higher initial 11 C-palmitate uptake and greater percent clearance. 23, 24 Initial Myocardial 11 
C-Acetate Uptake and Myocardial Blood Flow
Because the first-pass extraction fraction of 11 C-acetate is high, the initial uptake of 11 C-acetate correlates with regional myocardial blood flow. 16, 18, 19, 23 In the clinical setting, the relative net myocardial uptake of 11 C-acetate 60-180 s after its administration can be used as an index of regional relative myocardial blood flow. 16, 18, 19 
Relationships Among Myocardial Blood Flow, Fatty Acid -Oxidation, Total Oxidative Metabolism, and LV Wall Motion
As we have shown in this study, a significant correlation exists between the regional blood flow and regional total myocardial oxidative metabolism. The regions with good acetate-Kmono had good LV wall motion. In contrast, the interpretation of the relationships between palmitateoxidation, total myocardial oxidative metabolism, and LV regional wall motion may be a little complicated. In the present study, we have demonstrated that relative blood flow and acetate-Kmono were significantly greater in the regions having well-fitted monoexponential curves for 11 Cpalmitate clearance than in those having poorly fitted curves. As shown in Fig 5, in the regions having poorly fitted 11 C-palmitate clearance curves, the initial uptake of 11 C-palmitate was less and the percent clearance of 11 Cpalmitate from the myocardium was also less than the values for the segments having well-fitted 11 C-palmitate clearance curves. These findings indicate that fatty acidoxidation was depressed in the regions with poorly fitted 11 C-palmitate clearance curves. Thus, we consider that our hypothesis that in regions with an R 2 value ≥0.5, fatty acid -oxidation works well, whereas it does not in those with an R 2 value <0.5, is acceptable. As shown in Fig 8, in regions with an R 2 value ≥0.5, palmitate-Kmono values were relatively high, whereas in those with an R 2 value <0.5, palmitate-Kmono values were relatively low. Although one should not clinically use the palmitate-Kmono in the poorly fitted regions as an index of -oxidation, this finding may support our hypothesis that in the regions with an R 2 value <0.5, 11 C-palmitate clearance is relatively slow with impaired fatty acid -oxidation. The R 2 value itself has an aspect as an indicator of the activity of 11 C-palmitateoxidation in the myocardium. In the regions with wellfitted monoexponential curves for 11 C-palmitate clearance, palmitate-Kmono correlated significantly with acetate-Kmono. Palmitate-Kmono was significantly higher in the LV walls with normal wall motion than in those with hypokinesis. In the akinetic areas, a monoexponential curve could not be fitted for 11 C-palmitate clearance. The threshold R 2 value of 0.5 for monoexponential fitting also should be appropriate from the viewpoint of LV wall motion, because the lower 95% CI of the mean R 2 value in the hypokinetic regions was 0.51 and the upper 95% CI of the mean R 2 value in the akinetic regions was 0.49.
Energy Source Change in Oxidative Metabolism
As shown in Fig 7 , in the regions with relatively low palmitate-Kmono (<0.035), the segments with normal wall motion had a higher acetate-Kmono. In addition, several segments that belonged to the poorly fitted regions had hypokinetic wall motion with a relatively higher acetateKmono. A change in the metabolic source of oxidation from fatty acids to glucose may have contributed to these findings. [1] [2] [3] Further investigation of the quantitative glucose uptake in such regions using 18 F-fluorodeoxyglucose PET is needed.
Comparison With 123 I-15-(p-Iodophenyl)-3-(R,S) Methylpentadecanoic Acid (BMIPP) Single Photon Emission Computed Tomography (SPECT) Imaging
Resting 123 I-BMIPP myocardial SPECT imaging is able to detect not only coronary stenosis but also coronary spasm without the need for a stress examination. 26 Furthermore, the combined use of 123 I-BMIPP and 99m Tc-tetrofosmin myocardial SPECT can predict the functional recovery of infarcted myocardium after coronary reperfusion therapy. 27 The usefulness of 123 I-BMIPP myocardial imaging in patients with coronary artery disease was recently emphasized in the evaluation of myocardial pathophysiology. [26] [27] [28] The quantitative information regarding myocardial energy metabolism that we showed in this study may assist in the interpretation of 123 I-BMIPP myocardial SPECT images in patients having coronary artery disease, although 123 I-BMIPP imaging does not directly reflect myocardialoxidation, but rather fatty acid uptake and the turnover rate of triglycerides. 29 Methyl branching of the fatty acid chain retains the compounds in the myocardium while protecting against metabolism by -oxidation. 29 Accordingly, the trapped 123 I-BMIPP is incorporated into triglycerides and stays in the myocardium without rapid clearance, providing excellent myocardial images. 29 As the incorporation of triglyceride is an energy-dependent process, insufficient energy supply with deteriorated fatty acid -oxidation may provoke reduced or no 123 I-BMIPP uptake by the myocardium. 30 However, it should be realized that myocardial energy production can be evaluated by the total oxidative metabolism using the acetate-Kmono. In this study we demonstrated a comprehensive understanding of the relationship between fatty acid -oxidation and total oxidative metabolism.
Conclusion
In patients with prior MI and reperfusion therapy, the finding that the early-phase clearance of 11 C-palmitate is fitted to a monoexponential curve may provide substantial information for the evaluation of myocardial fatty acidoxidation. Acetate-Kmono and LV wall motion are better in the regions where the early-phase clearance of 11 C-palmitate fits a monoexponential curve well. Maintained myocardial fatty acid -oxidation is important in preserving total myocardial oxidative metabolism and LV wall motion.
